Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment
ACR/ARHP Annual Meeting 2012: Physicians Find Treatment Options Limited for Scleroderma Bowel Disease
With few proven medical treatments for scleroderma bowel disease, physicians often recommend a lifestyle change for patients as a first treatment option
ACR/ARHP Annual Meeting 2012: What Rheumatologists Need to Know about the New Oral Anticoagulants
A hematologist outlines how the new drugs can help treat coagulation triggered by rheumatological diseases
ACR/ARHP Annual Meeting 2012: Children Experience Pain Differently from Adults
Experts say children in pain from rheumatic diseases or other causes may have more discomfort because they can’t downregulate the pain as effectively as adults
The ARHP Honors Health Professionals for their Contributions to Rheumatology
The ARHP recognized individuals for their work in advancing rheumatology research, education, and patient care at the organizations’ annual meeting in Washington, D.C. last November
ACR/ARHP Annual Meeting 2012: Understanding Pain Signals May Pave Path to More Effective Therapies
The ability to differentiate the types of pain affiliated with rheumatic diseases can help rheumatologists better diagnose and treat patients
ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines
People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs
ACR/ARHP Annual Meeting 2012: Will Novel Strategies Lead to Breakthroughs in Treating Osteoarthritis?
ACR/ARHP Annual Meeting 2012: New Research Into Stem Cell Therapy and Drugs May Lead to Breakthrough Treatments for Osteoarthritis
Novel strategies for treating osteoarthritis aim to relieve pain, rebuild or replenish deteriorated cartilage and bone, or to replace the joint through surgery
ACR/ARHP Annual Meeting 2012: Early Signs of Rheumatoid Arthritis May Appear Outside the Joints
Evidence that suggests rheumatoid arthritis (RA) starts in mucosal sites such as the oral cavity and lung may lead to improved treatment and prevention of the disease
- « Previous Page
- 1
- …
- 79
- 80
- 81
- 82
- 83
- …
- 91
- Next Page »